EP1035823A1 - Multiple compartment container for medical solution - Google Patents
Multiple compartment container for medical solutionInfo
- Publication number
- EP1035823A1 EP1035823A1 EP98959333A EP98959333A EP1035823A1 EP 1035823 A1 EP1035823 A1 EP 1035823A1 EP 98959333 A EP98959333 A EP 98959333A EP 98959333 A EP98959333 A EP 98959333A EP 1035823 A1 EP1035823 A1 EP 1035823A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- glucose
- concentration
- calcium
- contents
- compartment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008155 medical solution Substances 0.000 title claims abstract description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 75
- 239000008103 glucose Substances 0.000 claims abstract description 74
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 57
- 239000011575 calcium Substances 0.000 claims abstract description 57
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 57
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 28
- 239000000243 solution Substances 0.000 claims abstract description 22
- 239000000385 dialysis solution Substances 0.000 claims abstract description 21
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 18
- 238000000502 dialysis Methods 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 238000003860 storage Methods 0.000 claims abstract description 7
- 230000007774 longterm Effects 0.000 claims abstract description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 18
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 4
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 22
- 239000011780 sodium chloride Substances 0.000 abstract description 11
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000001540 sodium lactate Substances 0.000 abstract description 4
- 229940005581 sodium lactate Drugs 0.000 abstract description 4
- 235000011088 sodium lactate Nutrition 0.000 abstract description 4
- 238000000108 ultra-filtration Methods 0.000 abstract description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 16
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 12
- 239000012528 membrane Substances 0.000 description 11
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 239000001110 calcium chloride Substances 0.000 description 7
- 229910001628 calcium chloride Inorganic materials 0.000 description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229940001447 lactate Drugs 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1668—Details of containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2027—Separating means having frangible parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
Definitions
- the present invention relates to peritoneal dialysis, where a dialysis solution is present in a multiple compartment container provided with three or more compartments.
- the invention relates particularly to such a container in which the dialysis solution contains bicarbonate as buffer, as well as glucose and calcium ions.
- a container for peritoneal dialysis is disclosed in WO 97/05852.
- the container contains conventional dialysis solution with lactate as buffer.
- the container thus comprises a first large compartment containing sodium lactate, sodium chloride, calcium chloride and magnesium chloride, as well as two small compartments containing glucose of high concentration and low pH.
- the container is sterilized in an autoclave with the solutions in situ in said compartments.
- either one or both of the compartments are connected to the large compartment by frangible pins whereby the dialysis solution contains a desired concentration of glucose, such as 1.5%, 2.5% or 4%.
- Using a three compartment container it is possible to employ a single container for all three degrees of concentration, which reduces costs for logistics and storage.
- An object to the present invention is to adapt the container according to WO 97/05852 for such type of peritoneal dialysis in which the lactate buffer is entirely or partially exchanged for a buffer consisting of bicarbonate.
- bicarbonate cannot, however, be combined with calcium or magnesium in the large compartment since this may lead to precipitation of, for example, carbonates during long term storage or at high pH. Accordingly, bicarbonate and calcium/magnesium must be separated until shortly before use.
- Glucose and calcium/magnesium are largely compatible, i.e. they do not precipitate.
- the divalent ions catalyse glucose decomposition to a certain extent .
- a conventional peritoneal dialysis solution has a calcium ion concentration of 1.75 mM (mmol/1) and a magnesium ion concentration between 0.25-0.50 mM.
- the buffer may be solely bicarbonate which thereby normally exists at a concentration of 30-40 mM or a combination of bicarbonate and lactate, for example 25 mM bicarbonate and 15 mM lactate.
- a further object of the present invention is to propose a three compartment container of the above-mentioned type in which the above-mentioned problem is solved.
- hypocalciemia results in i.a. the following symptoms: cramps, hyper-reflexes, spasms, ECG- changes and hyperparatyroidism.
- hypocalciemia is normally counteracted by increased intake of calcium carbonate, while the calcium concentration in the dialysis solution is normally kept constant .
- a peritoneal dialysis solution is to be neutral (in- and outflow the same) with regard to the calcium transport during a four hour period, it should comprise about 1.2 mM calcium at 1.5% glucose, about 1.6 mM at 2.5% glucose and, finally, about 2.3 mM calcium at 4.0% glucose, i.e. the calcium concentration should be substantially proportional to the glucose concentration in the final solution.
- the final glucose concentration in the mixed solution is determined by the volume of the small compartments since the glucose concentration is identical in the small glucose compartments, for example 50%. This results in that the calcium concentration will always remain proportional to the glucose concentration. The higher the glucose concentration (greater volume) , the more ultrafiltration and thus also higher calcium concentration in the mixed solution.
- the calcium concentration may in that respect be selected so that the patient either has a net loss, net gain or neutral calcium balance irrespective of the ultra- filtration and the glucose concentration.
- a further object in the present invention is to provide a three compartment container of the above-mentioned type with bicarbonate in the large compartment and glucose together with calcium in the two small compartments, whereby the increase in the calcium concentration at the highest glucose concentration results in better calcium control than previously.
- This invention is completely different from previously known methods in which the same calcium concentration has always been used irrespective of the glucose concentration.
- the large compartment comprises bicarbonate ions and the small compartments comprises glucose and calcium ions .
- the glucose concentration is substantially proportional to the calcium ion concentration in the finally prepared medical solution.
- the two small compartments may comprises solutions having the same concentration of glucose and calcium, though having different volumes, or the first of the small compartments contains glucose and calcium ions with such a concentration that the glucose concentration when mixing the contents of said first small compartment with the contents of the large comparment obtains a first predetermined value, such as 1.5%, and the calcium ion concentration obtains a second predetermined value, such as 1.0 mM, while the second of the small compartments contains glucose and calcium ions having such a concentration so that the glucose concentration in the finally prepared solution when mixing the contents of said second small compartment with the contents of the large comparment obtains a third predetermined value, such as 2.5%, and the calcium ion concentration obtains a fourth predetermined value, such as 1.6 mM, and finally the contents of the first and the second of the small compartments may be mixed with the contents of the large compartment to obtain a finally prepared solution with higher concentrations of glucose and calcium ions, such as 4% glucose concentration and 2.5 mM calcium.
- a first predetermined value such as 1.5%
- the small compartments may further comprise magnesium ions, for example in a concentration such that the resulting concentration in the finally prepared medical solution is about 0.25-0.75 mM.
- the invention also relates to a method for preparing a medical solution, particularly for peritoneal dialysis, in a container consisting of a first large compartment having a volume which is sufficiently large to contain the finally prepared medical solution, and a plurality of small compartments which contain partial quantities of the medical solution which are not compatible for long term storage with the contents of the large compartment.
- the large compartment comprises bicarbonate ions and the small compartments comprise glucose and calcium ions.
- the contents of one or more of the small compartments are mixed with the contents of the large compartment to produce a medical solution in which the concentration of glucose is substantially proportional to the concentration of calcium ions.
- the invention also relates to a use of a container for preparation of a peritoneal dialysis solution in which the concentrations of glucose and calcium ions are substantially proportional.
- Fig. 1 is a plan view of a container which may be used in the present invention.
- Figs. 2, 3 and 4 are computer-simulated diagrams which show the calcium balance across the peritoneal membrane.
- Fig. 1 discloses a three compartment container which may be used in the present invention.
- the container 1 is of the type which is sealed at both ends with weld seams 20 and 21.
- the container is divided into a large compartment 10 and two small compartments 14 and 15 by weld seams 11, 12 and 13.
- the small compartment 14 and/or 15 may communicate with the large compartment 10 by means of frangible pins 18, 19 which are normally sealed but can be manually opened. When the frangible pin 18 and/or 19 is opened, the contents in the compartments 14 and/or 15 flow down into the large compartment
- suitable solution is supplied to the various compartments 10, 14 and 15 via inlet tubes 16, 17 and 22 extending through the weld seams 20 and 21.
- a sample and/or infusion port 23 extending through the weld seam 21 permits sampling from, and infusion to, the compartment 10.
- the solution in the compartment 10 is supplied to a patient via a conduit 24.
- the container is placed on a stand by means of an opening 25 in the upper weld seam 20.
- the bag described so far is substantially identical to the one disclosed in WO 97/05852.
- the container preferably has a size such that two litres of peritoneal dialysis solution are accommodated in the large compartment 10 in a ready-mixed state. Larger or smaller containers are of course feasible according to the invention.
- the container 1 is to be used to prepare a peritoneal dialysis solution in which the buffer consists of bicarbonate. Accordingly, the solutions in the various compartments may be the following.
- EXAMPLE 1 The compartment 10 contains 1900 ml with the composition:
- Compartment 14 contains 100 ml of the composition:
- Compartment 15 contains 100 ml of the composition:
- a peritoneal dialysis solution is obtained with the following composition:
- a dialysis solution having the following composition:
- each of the small compartments has the same composition according to the following:
- Compartment 10 contains 1950 ml of the composition:
- Compartment 14 contains 60 ml of the composition:
- solutions are employed with the following compositions in the various compartments 10, 14 and 15.
- Compartment 10 contains 1850 ml of the composition:
- Compartment 14 contains 150 ml of the composition:
- Compartment 15 contains 260 ml of the composition:
- the calcium concentration will be somewhat lower than in the first two examples .
- the pH- value in the small compartments is normally low, about 3.0, in order to prevent glucose decomposition during autoclaving.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- External Artificial Organs (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704386 | 1997-11-28 | ||
SE9704386A SE512349C2 (sv) | 1997-11-28 | 1997-11-28 | Flerkammarbehållare för medicinsk lösning, förfarnde för beredning av medicinsk lösning för peritonealdialys samt användning av sådan behållare vid beredning av medicinsk lösning |
PCT/SE1998/002146 WO1999027885A1 (en) | 1997-11-28 | 1998-11-27 | Multiple compartment container for medical solution |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1035823A1 true EP1035823A1 (en) | 2000-09-20 |
Family
ID=20409165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98959333A Withdrawn EP1035823A1 (en) | 1997-11-28 | 1998-11-27 | Multiple compartment container for medical solution |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1035823A1 (ko) |
JP (1) | JP2001524353A (ko) |
KR (1) | KR20010032191A (ko) |
CN (1) | CN1280481A (ko) |
AU (1) | AU742793B2 (ko) |
BR (1) | BR9815055A (ko) |
CA (1) | CA2311903A1 (ko) |
SE (1) | SE512349C2 (ko) |
WO (1) | WO1999027885A1 (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996001118A1 (en) | 1994-07-01 | 1996-01-18 | Baxter International Inc. | Biochemically balanced peritoneal dialysis solutions |
JP3060133U (ja) * | 1997-10-27 | 1999-07-30 | 株式会社大塚製薬工場 | 眼灌流・洗浄液バッグ包装体 |
DE19912850B4 (de) † | 1999-03-22 | 2005-04-07 | Fresenius Medical Care Deutschland Gmbh | Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung |
US6818179B1 (en) | 1999-03-30 | 2004-11-16 | Gambro Lundia Ab | Method and apparatus for sterilizing a heat sensitive fluid |
SE9903331D0 (sv) | 1999-09-16 | 1999-09-16 | Gambro Lundia Ab | Method and apparatus for sterilising a heat sensitive fluid |
US7122210B2 (en) * | 2002-01-11 | 2006-10-17 | Baxter International Inc. | Bicarbonate-based solutions for dialysis therapies |
SE524531C2 (sv) * | 2002-12-10 | 2004-08-24 | Gambro Lundia Ab | Metod för att framställa en medicinsk lösning för peritonealdialys där en lösning innehållandes ett eller flera acetylerade eller deacetylerade aminosocker värme- eller strålningssteriliseras med bestämda pH-värden och med bestämda viktsprocent för att undvika att cytotoxiska produkter bildas |
JP4361493B2 (ja) * | 2002-12-10 | 2009-11-11 | ガンブロ・ルンディア・エービー | 腹膜透析用薬剤の製造のための医学的溶液を調製する方法 |
SE524530C2 (sv) * | 2002-12-10 | 2004-08-24 | Gambro Lundia Ab | Metod för att framställa en medicinsk lösning för peritonealdialys där en lösning innehållandes ett eller flera acetylerade eller deacetylerade aminosocker värme- eller strålningssteriliseras med bestämda pH-värden och med bestämda viktsprocent för att undvika att cytotoxiska produkter bildas. |
KR101142863B1 (ko) | 2002-12-10 | 2012-05-21 | 프레제니우스 메디칼 케어 도이칠란드 게엠베하 | 복막 투석용 약제를 제조하기 위한 의료용 용액의 제조방법 |
SE0301577L (sv) | 2003-05-28 | 2004-11-29 | Gambro Lundia Ab | Lösning med låg natriumhalt |
US9004761B2 (en) | 2006-05-01 | 2015-04-14 | Baxter International Inc. | Multiple chamber container with mistake proof administration system |
DE102010039489A1 (de) * | 2010-08-18 | 2012-02-23 | Fresenius Medical Care Deutschland Gmbh | Konzentrat |
ES2875060T3 (es) | 2013-06-07 | 2021-11-08 | Allena Pharmaceuticals Inc | Composiciones y dispositivos para diálisis |
DK178893B1 (en) * | 2015-07-05 | 2017-05-01 | Dorte Dyrsborg | Intravenous Bag |
WO2017038959A1 (ja) * | 2015-09-03 | 2017-03-09 | 太 宮崎 | キット製剤及び用量調整方法 |
DE102018103937A1 (de) * | 2018-02-21 | 2019-08-22 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung enthaltend Dialyselösung oder Dialyselösungskonzentrat |
US20210205172A1 (en) | 2018-08-17 | 2021-07-08 | Regimen Kit, Inc. | Drug management method for kit formulation requiring dose adjustment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH686778A5 (fr) * | 1987-05-29 | 1996-06-28 | Vifor Medical Ag | Récipient destiné au stockage séparé de composés actifs et à leur mélange subséquent. |
EP0442406B1 (en) * | 1990-02-14 | 1995-07-26 | Material Engineering Technology Laboratory, Inc. | Filled and sealed, self-contained mixing container |
-
1997
- 1997-11-28 SE SE9704386A patent/SE512349C2/sv not_active IP Right Cessation
-
1998
- 1998-11-27 CN CN98811625A patent/CN1280481A/zh active Pending
- 1998-11-27 JP JP2000522874A patent/JP2001524353A/ja active Pending
- 1998-11-27 KR KR1020007005381A patent/KR20010032191A/ko not_active Application Discontinuation
- 1998-11-27 WO PCT/SE1998/002146 patent/WO1999027885A1/en not_active Application Discontinuation
- 1998-11-27 BR BR9815055-3A patent/BR9815055A/pt unknown
- 1998-11-27 EP EP98959333A patent/EP1035823A1/en not_active Withdrawn
- 1998-11-27 AU AU15153/99A patent/AU742793B2/en not_active Ceased
- 1998-11-27 CA CA002311903A patent/CA2311903A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO9927885A1 * |
Also Published As
Publication number | Publication date |
---|---|
SE9704386L (sv) | 1999-05-29 |
JP2001524353A (ja) | 2001-12-04 |
WO1999027885A1 (en) | 1999-06-10 |
KR20010032191A (ko) | 2001-04-16 |
SE512349C2 (sv) | 2000-03-06 |
CN1280481A (zh) | 2001-01-17 |
AU1515399A (en) | 1999-06-16 |
BR9815055A (pt) | 2002-04-30 |
CA2311903A1 (en) | 1999-06-10 |
SE9704386D0 (sv) | 1997-11-28 |
AU742793B2 (en) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU742793B2 (en) | Multiple compartment container for medical solution | |
AU779950B2 (en) | Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy | |
TWI326597B (en) | Bicarbonate-based solutions for dialysis therapies | |
AU743889B2 (en) | Safety arrangement for a dialysis machine and method of activating the safety arrangement | |
JP3034303B2 (ja) | ヒスチジン緩衝の腹膜透析溶液 | |
US9265874B2 (en) | Production of individual concentrate | |
MXPA06014254A (es) | Soluciones para dialisis peritoneal a base de bicarbonato. | |
CA2566326C (en) | Peritoneal dialysis solution | |
WO1998010745A1 (en) | Batch quantity dialysate chemical formulations | |
JP2001187111A (ja) | マルチ・チャンバ容器 | |
CN109758632A (zh) | 多容器系统及其用途 | |
US20080149515A1 (en) | Container containing at least two solids and use thereof | |
JP4135849B2 (ja) | 溶液、とくに、血液透析または腹膜透析のための溶液およびその調製方法 | |
CN105640930A (zh) | 铁代谢改善剂 | |
JPH08131542A (ja) | 腹膜透析液調製用溶液セット | |
WO2003103688A1 (en) | A stable bicarbonate-based solution in a single container | |
US10471197B2 (en) | Connector with a container for preparing an individually adjusted solution for dialysis | |
JP2000245826A (ja) | 中性腹膜透析液 | |
JP2003052813A (ja) | 溶液製造方法及び装置、並びに溶液製造に用いるコネクター及び濃縮物用容器ユニット | |
MXPA00005012A (en) | Multiple compartment container for medical solution | |
Havard | Symposium: Salt and Water [Abridged] Thiazide-Induced Antidiuresis in Diabetes Insipidus | |
Chebrolu et al. | Phosphorus-enriched hemodialysis for the treatment of patients with severe methanol intoxication | |
JP2003088582A (ja) | 腹膜透析液および保存容器 | |
CN101568334A (zh) | 铁代谢改善剂 | |
Mayer | Diet and renal disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000628 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20010918 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030611 |